Antioxidant Treatment in Alzheimer's Disease: Current State
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 21 (1) , 1-12
- https://doi.org/10.1385/jmn:21:1:1
Abstract
Accumulating data from experimental and human studies indicate that oxidative stress (OS) plays a major role in the pathogenesis of Alzheimer’s disease (AD). The production of reactive oxygen species...Keywords
This publication has 51 references indexed in Scilit:
- Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Aβ1–42 in glioma cell culture in vitroPharmacological Research, 2003
- Antioxidants and Alzheimerʼs disease: from bench to bedside (and back again)Current Opinion in Clinical Nutrition and Metabolic Care, 2002
- Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptideTrends in Molecular Medicine, 2001
- Aging: Is Oxidative Stress a Marker or Is It Causal?Proceedings of the Society for Experimental Biology and Medicine, 1999
- The Role of Excitotoxicity in Neurodegenerative DiseasePharmacology & Therapeutics, 1999
- Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's diseaseAnnals of Neurology, 1998
- Increased Peroxidation and Reduced Antioxidant Enzyme Activity in Alzheimer's DiseaseExperimental Neurology, 1998
- Aging, energy, and oxidative stress in neurodegenerative diseasesAnnals of Neurology, 1995
- Oxidative damage to mitochondrial DNA is increased in Alzheimer's diseaseAnnals of Neurology, 1994
- Role of Free Radicals in Aging and DiseaseAnnals of the New York Academy of Sciences, 1992